In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion-Reference-Cited by-同舟云学术

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion

Published:2021-09-14 Issue:1 Volume:77 Page:111-117
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Augusto Gilles¹²³^ORCID,Mohsen Mona O.¹²,Zinkhan Simon¹²^ORCID,Liu Xuelan¹⁴,Vogel Monique¹²^ORCID,Bachmann Martin F.¹²³⁴

Affiliation:

1. Department of Immunology University clinic of Rheumatology and Immunology, Inselspital Bern Switzerland

2. Department of BioMedical Research University of Bern Bern Switzerland

3. The Jenner Institute University of Oxford Oxford UK

4. International Immunology Centre Anhui Agricultural University Hefei China

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15065

Reference18 articles.

1. Convergent antibody responses to SARS-CoV-2 in convalescent individuals

2. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody

3. Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study

4. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

5. The E484K mutation in the SARS‐CoV‐2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post‐vaccination sera;Jangra S;medRxiv,2021

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding affinity between coronavirus spike protein and human ACE2 receptor;Computational and Structural Biotechnology Journal;2024-12

2. Vaccination status and disease severity of COVID-19 in different phases of the pandemic;Human Vaccines & Immunotherapeutics;2024-06-04

3. Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization;Journal of Proteome Research;2024-04-11

4. A High-Throughput Computational Pipeline for Selection of Effective Antibody Therapeutics Against Viruses;Livestock Diseases and Management;2024

5. Disease severity of COVID-19 in different phases of the pandemic: Do healthcare workers have better outcomes?;Vaccine: X;2023-12